Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
2
×
detroit top stories
fda
gilead sciences
incyte
indiana blog main
2
×
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accent therapeutics
aducanumab
alector
alkermes
alzheimer's disease
amblyotech
asklepios biopharmaceutical
avrobio
baricitinib
bcma
bioeurope
What
bio
isn’t
2
×
new
2
×
roundup
activity
approvals
biogen
biopharma
clamped
congress
congressional
covid
crispr
delays
developing
economic
executives
fast
fda
feud
group
including
ipo
known
later
lot
medicines
month
ny
oric’s
pharma
roster
showing
spectacles
splash
spread
stay
testify
testing
tuned
Language
unset
Current search:
new
×
" detroit blog main "
×
" indiana blog main "
×
isn’t
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More